tetano
Editor, Senior Moderator
J Korean Med Sci
. 2022 Aug 15;37(32):e250.
doi: 10.3346/jkms.2022.37.e250.
The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea
Sang Hyuk Kim[SUP] #[/SUP][SUP] 1 [/SUP], Byung Woo Jhun[SUP] #[/SUP][SUP] 2 [/SUP], Byeong-Ho Jeong[SUP] 2 [/SUP], Hye Yun Park[SUP] 2 [/SUP], Hojoong Kim[SUP] 2 [/SUP], O Jung Kwon[SUP] 2 [/SUP], Sun Hye Shin[SUP] 3 [/SUP]
Affiliations
Abstract
The aim of our study was to investigate the incidence of and risk factors for coronavirus disease 2019 (COVID-19) in patients with non-tuberculous mycobacterial-pulmonary disease (NTM-PD). A total of 3,866 patients with NTM-PD were retrospectively identified from a single center. Compared to the general population of Korea, patients with NTM-PD had a substantially increased age-standardized incidence of COVID-19 from January 2020 to February 2021 (2.1% vs. 0.2%). The odds of being infected with COVID-19 was particularly higher in patients who received treatment for NTM-PD than in those who did not receive treatment for NTM-PD (adjusted odd ratio = 1.99, 95% confidence interval = 1.09-3.64, P = 0.026). Patients with NTM-PD might be regarded as a high-risk group for COVID-19 and may need a more proactive preventive strategy for COVID-19 and other pandemics in the future.
Keywords: Coronavirus; Epidemiology; Mycobacterium; Nontuberculous Mycobacteria; Public Health; Viruses.
. 2022 Aug 15;37(32):e250.
doi: 10.3346/jkms.2022.37.e250.
The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea
Sang Hyuk Kim[SUP] #[/SUP][SUP] 1 [/SUP], Byung Woo Jhun[SUP] #[/SUP][SUP] 2 [/SUP], Byeong-Ho Jeong[SUP] 2 [/SUP], Hye Yun Park[SUP] 2 [/SUP], Hojoong Kim[SUP] 2 [/SUP], O Jung Kwon[SUP] 2 [/SUP], Sun Hye Shin[SUP] 3 [/SUP]
Affiliations
- PMID: 35971764
- DOI: 10.3346/jkms.2022.37.e250
Abstract
The aim of our study was to investigate the incidence of and risk factors for coronavirus disease 2019 (COVID-19) in patients with non-tuberculous mycobacterial-pulmonary disease (NTM-PD). A total of 3,866 patients with NTM-PD were retrospectively identified from a single center. Compared to the general population of Korea, patients with NTM-PD had a substantially increased age-standardized incidence of COVID-19 from January 2020 to February 2021 (2.1% vs. 0.2%). The odds of being infected with COVID-19 was particularly higher in patients who received treatment for NTM-PD than in those who did not receive treatment for NTM-PD (adjusted odd ratio = 1.99, 95% confidence interval = 1.09-3.64, P = 0.026). Patients with NTM-PD might be regarded as a high-risk group for COVID-19 and may need a more proactive preventive strategy for COVID-19 and other pandemics in the future.
Keywords: Coronavirus; Epidemiology; Mycobacterium; Nontuberculous Mycobacteria; Public Health; Viruses.